Sunday, March 15, 2026
  • Home
  • About us
  • Privacy policy
  • Advertise with us
  • Contact us
Fii News Logo
No Result
View All Result
  • Tenders
  • Projects
  • Markets
  • Manufacturing
  • Investment
  • Technology
  • Exports
Newsletter
  • Tenders
  • Projects
  • Markets
  • Manufacturing
  • Investment
  • Technology
  • Exports
Fiinews
No Result
View All Result
Home Markets

Market: Pharma contract manufacturing to grow at 13.3% CAGR

Fiinews by Fiinews
October 20, 2022
in Markets
Reading Time: 2 mins read
A A
0
Aurobindo
0
SHARES
11
VIEWS
LinkedinShare on Twitter

Manufacturing edge: 58 companies are certified by US FDA, WHO, MCC and MHRA

The Indian pharmaceutical contract manufacturing market is anticipated to grow at a favourable CAGR of around 13.3% during 2022-28, as India, being one of the free trade agreement members, holds the access to the best established and emerging pharmaceutical markets in the Asia-Pacific region.

Due to the favorable factors, such as low manufacturing cost, easy availability of skilled workers, and well-established certified plants, the Indian pharmaceutical contract manufacturing has witnessed higher growth, said the report “Indian Pharmaceutical Contract Manufacturing Market Research and Forecast 2022-2028”.

Nearly 58 companies have certification including Emcure Pharmaceuticals Ltd which is certified with US FDA, WHO, Medical Control Council (MCC) and the Medicine and Healthcare products Regulatory Authority of the United Kingdom, according to the report released on 19 Oct 2022.

In basic manufacturing of medical drugs and devices, India has a superior edge over nations, such as Vietnam, China and Ireland, owing to the availability of immense raw material, technical workforce and WHO-approved production premises.

During the COVID-19 pandemic, several initiatives were taken by the Union Cabinet to boost the Indian pharmaceutical industry, which includes the amendment of the existing foreign direct investment (FDI), which allows the foreign investors to invest up to 100% under the automatic route for manufacturing medical devices.

With the advent of global pharmaceutical organizations, and their vast presence in India, the concept of contract manufacturing has steadily evolved, which in turn boosts the growth of India’s pharmaceutical contract manufacturing market, said the report.

Leading companies in the sector are:

Agrata Biotech Ltd

Ankur Drugs and Pharma Ltd

Aurobindo Pharma

BDR Pharmaceuticals Internationals Pvt Ltd

Ceegolabs Pvt Ltd

Ciron Drugs & Pharmaceuticals Pvt Ltd

Contract Pharmaceuticals Ltd

Cosway Biosciences

Cubic Lifesciences Pvt Ltd

Daffohils Laboratories Pvt Ltd. fiinews.com

Tags: ResearchAndMarkets
ShareTweetShare

Related Posts

Trigent
Markets

Market: Bengaluru-Hyderabad to get new GCCs

by Fiinews
March 14, 2026
0
12

Trigent will build-operationalize both innovation centres, says Qadri Trigent Software, a US-based technology services company and Global Capability Centre (GCC)...

Department of Environment, Food and Rural Affairs, UK.
Markets

Market: UK presents brands at AAHAR 2026

by Fiinews
March 12, 2026
0
16

Birrell determined to help UK exporters to sell more in India Following the signature of the landmark UK-India Free Trade...

ScienceLogic

Market: Nanakramguda to support ScienceLogic in AP

March 11, 2026
19
Infineum

Market: Infineum expands facility for growth

March 11, 2026
19
Fazer

Market: Indians set to get Finnish chocolates

March 8, 2026
11
ThoughtFocus

Market: Kochi leadsThoughtFocus’ global expansion

March 6, 2026
22
SBI YONO

POPULAR NEWS

  • Cristina Dnv

    Projects: Indian yards set to build green ships, says DNV expert

    0 shares
    Share 0 Tweet 0
  • Market: Indian-origin UGF scales heritage consumer brands globally

    0 shares
    Share 0 Tweet 0
  • Technologies: Royal Diamond sponsors aerspace Industries’ drones in UAE

    0 shares
    Share 0 Tweet 0
  • Investments: Foreign investors see India as long-term destination for fund placings

    0 shares
    Share 0 Tweet 0
  • Markets: Blue Dart maintains positive outlook on India

    0 shares
    Share 0 Tweet 0

Fiinews.com features through news articles on business opportunities in the Indian market for the benefits of foreigners. It is also a platform for international businesses to showcase through elaborate articles on their products & services to the Indian consumers and corporations exploiting industrialisation of the country.

7Clicks Media is a Singapore based Media & PR company offering over 100,000
impressions via our targeted communication strategy.

It is led by editor-in-chief Gurdip Singh who has worked over 45 years reporting on
Asian businesses.

Recent News

  • Export: Industry told to exploit India-EFTA
  • Market: Bengaluru-Hyderabad to get new GCCs
  • Invest: Tech helped NSE crosses 11 crore investors
  • Invest: Gift Nifty captures global market trends
  • Project: Partnership to work on low-carbon economy

Pages

  • About US
  • ADVERTISE ON FIINEWS.COM
  • CONTACT US
  • EVENTS
  • FII-NEWS.COM PDF ARCHIVE
  • Home
  • News
  • PRIVACY POLICY

Subscribe to Newsletter

  • About
  • Advertise
  • Careers
  • Contact us

© 2024 FIINEWS - Design and developed by 7clicksmedia.

No Result
View All Result
  • Tenders
  • Projects
  • Markets
  • Manufacturing
  • Investment
  • Technology
  • Exports

© 2024 FIINEWS - Design and developed by 7clicksmedia.